Clinical Trial Update: Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating intra-ovarian injection of mesenchymal stem cell-derived extracellular vesicles for idiopathic premature ovarian failure, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ovarian Failure

Drugs mentioned

• MSC-EVs (mesenchymal stem cell-derived extracellular vesicles)

Snippet

Sponsor: Royan Institute | Conditions: Premature Ovarian Failure | Phase 1, Phase 2 | Status: UNKNOWN